Medical Professionals Reference (MPR)Study Reaffirms Health Benefits of Universal Hepatitis B Birth Dose

The CDC abandoned universal hepatitis B birth dose recommendations in December 2025, allowing parents to opt out despite no safety or efficacy evidence supporting the change. Universal birth dosing has reduced pediatric hepatitis B incidence 99% since 1991; the AAP continues to recommend the birth dose for most infants.

⚖️ Professional Impact

• A comprehensive review found no evidence supporting delay of hepatitis B vaccination beyond birth for infants of HBsAg-negative mothers
• Anti-HBs serology testing to guide vaccination decisions has no supporting studies for predicting long-term protective immunity
• CDC’s advisory committee failed to account for health equity risks created by shifting to parental opt-in vaccination timing
• AAP maintains the birth dose recommendation within 24 hours, creating a direct conflict with new CDC guidance

🎯 Action Items

• Continue offering hepatitis B birth dose within 24 hours per AAP guidelines
• Document vaccine counseling conversations when parents request deferral
• Inform families that parental opt-out carries no evidence-based safety advantage
• Monitor AAP and CDC guidance updates for reconciliation of conflicting recommendations

More in Hepatitis